On Friday, Atyr Pharma Inc (NASDAQ: ATYR) opened higher 6.05% from the last session, before settling in for the closing price of $0.77. Price fluctuations for ATYR have ranged from $0.68 to $7.29 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 34.28%. Company’s average yearly earnings per share was noted 6.55% at the time writing. With a float of $94.38 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Atyr Pharma Inc is 3.68%, while institutional ownership is 64.55%. The most recent insider transaction that took place on Oct 08 ’25, was worth 612,437. In this transaction Director of this company bought 682,001 shares at a rate of $0.90, taking the stock ownership to the 1,095,024 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Director bought 317,999 for $0.94, making the entire transaction worth $299,364. This insider now owns 1,413,023 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.18 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.23) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.30% during the next five years compared to 34.28% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Check out the current performance indicators for Atyr Pharma Inc (ATYR). In the past quarter, the stock posted a quick ratio of 5.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 421.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Compared to the last year’s volume of 4.94 million, its volume of 3.64 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 13.87%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 2.05%, which indicates a significant decrease from 23.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0594 in the past 14 days, which was lower than the 0.3083 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8428, while its 200-day Moving Average is $3.6359. Nevertheless, the first resistance level for the watch stands at $0.8504 in the near term. At $0.8838, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9377. If the price goes on to break the first support level at $0.7631, it is likely to go to the next support level at $0.7092. Now, if the price goes above the second support level, the third support stands at $0.6758.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are currently 97,987K shares outstanding in the company with a market cap of 80.05 million. Presently, the company’s annual sales total 240 K according to its annual income of -64,020 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -19,530 K.
